[1]
I. Araujo-Filho and A. C. . Meneses do Rêgo, “Neoadjuvant Immunotherapy as a risk factor for Hashimoto’s Disease”, J Surg Cl Res, vol. 15, no. 2, pp. 187–199, Dec. 2024.